BAY CITY CAPITAL
Bay City Capital LLC (Bay City Capital) was established in 1997 for the purpose of managing investment funds in the life sciences industry. Since that date, they have managed six venture funds representing $1.5 billion in capital invested in over 70 companies. Five of these funds are general life sciences funds, and one is a nutrition and agribusiness sector fund.
BAY CITY CAPITAL
Industry:
Biotechnology
Founded:
1997-01-01
Status:
Active
Contact:
415.676.3830
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics WordPress Google Universal Analytics Nginx Sitelinks Search Box Microsoft Exchange Online IPv6
Similar Organizations
Clarus Ventures
Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
Reaction Biology
Reaction Biology is an industry leader and innovator specializing in assay services and protein production for early-stage drug discovery
Current Advisors List
Richard Myers Scientific Advisory Board @ Bay City Capital Advisor
Tadaharu Wakabayashi Advisor @ Bay City Capital Advisor
Fred Gage Scientific Advisory Board @ Bay City Capital Advisor
Israel Charo Scientific Advisory Board @ Bay City Capital Advisor
Carl Goldfischer Advisor @ Bay City Capital Advisor
Lester Kaplan Scientific Advisory Board @ Bay City Capital Advisor
Jeffrey Friedman Scientific Advisory Board @ Bay City Capital Advisor
E Rolland Dickson Scientific Advisory Board @ Bay City Capital Advisor
Current Employees Featured
Fred Craves
Fred Craves Managing Director @ Bay City Capital Managing Director 1997-01-01
David Beier
David Beier Managing Director @ Bay City Capital Managing Director 2013-03-01
Lionel Carnot
Lionel Carnot Managing Director @ Bay City Capital Managing Director 2005-01-01
Marge Josephson
Marge Josephson Vice President, Human Resources and Operational Services @ Bay City Capital Vice President, Human Resources and Operational Services 2005-01-01
Judy Koh
Judy Koh Managing Director/Chief Financial Officer @ Bay City Capital Managing Director/Chief Financial Officer 1998-04-01
Matt Kronmiller
Matt Kronmiller Vice President @ Bay City Capital Vice President 2013-12-01
Nathan Pliam
Nathan Pliam Venture Partner @ Bay City Capital Venture Partner
Rob Hopfner
Rob Hopfner Managing Director @ Bay City Capital Managing Director 2002-08-01
Denis O&s;Sullivan
Denis O'Sullivan Coordinating Principal @ Bay City Capital Coordinating Principal
Susan Vuong
Susan Vuong CFO @ Bay City Capital CFO 2015-06-01
Founder
Fred Craves
John Diekman
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-05-04 | Oculis | Bay City Capital investment in Series C - Oculis | 57 M USD |
2020-11-13 | Bridge Medicines | Bay City Capital investment in Venture Round - Bridge Medicines | 10 M USD |
2020-10-01 | Sembiosys Genetics | Bay City Capital investment in Venture Round - Sembiosys Genetics | N/A |
2020-03-02 | Xilio Therapeutics | Bay City Capital investment in Series B - Xilio Therapeutics | 100.5 M USD |
2019-03-18 | Imara | Bay City Capital investment in Series B - Imara | 63 M USD |
2018-11-13 | NextCure | Bay City Capital investment in Series B - NextCure | 93 M USD |
2018-07-23 | Gossamer Bio | Bay City Capital investment in Series B - Gossamer Bio | 230 M USD |
2018-01-05 | KBP Biosciences | Bay City Capital investment in Series A - KBP Biosciences | 76 M USD |
2018-01-04 | Oculis | Bay City Capital investment in Series B - Oculis | 20 M CHF |
2017-10-01 | Gritstone Bio | Bay City Capital investment in Venture Round - Gritstone Bio | N/A |